Kareem Ebeid
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 7
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Aliasger K. Salem (17 shared papers)Sean M. Geary (6 shared papers)Emad Ibrahim Wafa (6 shared papers)Youssef Wahib Naguib (7 shared papers)Angie S. Morris (2 shared papers)Amaraporn Wongrakpanich (2 shared papers)Xiangbing Meng (3 shared papers)Aml I. Mekkawy (3 shared papers)
- Journals
- Bioconjugate Chemistry (2 papers)Science Advances (2 papers)Biomaterials (2 papers)Gynecologic Oncology (1 paper)ACS Nano (1 paper)
- Partner nations
- United StatesEgyptThailand
In The Last Decade
Kareem Ebeid
20 papers receiving 435 citations
Peers
Comparison fields: 5 of 57
- Drug Discovery 4
- Biomaterials 137
- Pharmaceutical Science 27
- Organic Chemistry 56
- Hepatology 14
Countries citing papers authored by Kareem Ebeid
This map shows the geographic impact of Kareem Ebeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kareem Ebeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kareem Ebeid more than expected).
Fields of papers citing papers by Kareem Ebeid
This network shows the impact of papers produced by Kareem Ebeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kareem Ebeid. The network helps show where Kareem Ebeid may publish in the future.
Co-authors
The 25 scholars most cited alongside Kareem Ebeid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 72 | |
| 2 | 2015 | 51 | |
| 3 | 2022 | 51 | |
| 4 | 2017 | 30 | |
| 5 | 2022 | 30 | |
| 6 | 2022 | 26 | |
| 7 | 2017 | 24 | |
| 8 | 2021 | 23 | |
| 9 | 2019 | 20 | |
| 10 | 2021 | 19 | |
| 11 | 2023 | 17 | |
| 12 | 2023 | 16 | |
| 13 | 2024 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2019 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2026 | 2 | |
| 20 | 2016 | 1 |
About Kareem Ebeid
Kareem Ebeid is a scholar working on Biomaterials, Immunology, Molecular Biology, Oncology and Pharmaceutical Science, having authored 20 papers that have together received 443 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Immunotherapy and Immune Responses (3 papers), RNA Interference and Gene Delivery (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Cancer therapeutics and mechanisms (2 papers), Synthesis and biological activity (2 papers), Analytical Methods in Pharmaceuticals (1 paper) and Healthcare and Venom Research (1 paper). The work is most often cited by research in Drug Discovery (4 citations), Biomaterials (137 citations), Pharmaceutical Science (27 citations), Organic Chemistry (56 citations) and Hepatology (14 citations). Kareem Ebeid has collaborated with scholars based in United States, Egypt and Thailand. Frequent co-authors include Aliasger K. Salem, Sean M. Geary, Emad Ibrahim Wafa, Youssef Wahib Naguib, Angie S. Morris, Amaraporn Wongrakpanich, Xiangbing Meng, Aml I. Mekkawy, Hamada Hashem and Kristina W. Thiel. Their work appears in journals such as Bioconjugate Chemistry, Science Advances, Biomaterials, Gynecologic Oncology and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.